CSIMarket
 


Mylan N v   (MYL)
Other Ticker:  
 
 

MYL's Income from Cont. Operations Growth by Quarter and Year

Mylan N V 's Income from Cont. Operations results by quarter and year




MYL Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 20.50 51.20 661.10
III Quarter September 185.70 189.80 176.70 88.30
II Quarter June 39.40 -168.50 37.50 66.40
I Quarter March 20.80 -25.00 87.10 417.50
FY   245.90 16.80 352.50 1,233.30



MYL Income from Cont. Operations third quarter 2020 Y/Y Growth Comment
Mylan N V reported decrease in Income from Cont. Operations in the third quarter by -2.16% to $ 185.70 millions, from the same quarter in 2019.
The decrease in the third quarter Mylan N V 's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations rise of 39.24%.

Looking into third quarter results within Major Pharmaceutical Preparations industry 26 other companies have achieved higher Income from Cont. Operations growth. While Mylan N V ' s Income from Cont. Operations decline of -2.16% ranks overall at the positon no. 1227 in the third quarter.




MYL Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - -59.96 % -92.26 % -
III Quarter September -2.16 % 7.41 % 100.11 % -47.57 %
II Quarter June - - -43.52 % 377.7 %
I Quarter March - - -79.14 % 114.54 %
FY   - -95.23 % -71.42 % 379.7 %

Financial Statements
Mylan N V 's third quarter 2020 Income from Cont. Operations $ 185.70 millions MYL's Income Statement
Mylan N V 's third quarter 2019 Income from Cont. Operations $ 189.80 millions Quarterly MYL's Income Statement
New: More MYL's historic Income from Cont. Operations Growth >>


MYL Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - -89.2 % -71.02 % 648.7 %
III Quarter September 371.32 % - 371.2 % 32.98 %
II Quarter June 89.42 % - -56.95 % -84.1 %
I Quarter March 1.46 % - -86.82 % -
FY (Year on Year)   - -95.23 % -71.42 % 379.7 %




Income from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #27
Healthcare Sector #102
Overall #1227

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
552.41 % 39.24 % -92.26 %
(Dec 31 2011)   (Dec 31 2018)
Income from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #27
Healthcare Sector #102
Overall #1227
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
552.41 % 39.24 % -92.26 %
(Dec 31 2011)   (Dec 31 2018)

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mylan N V 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
1111.51 % 79.38 % -92.86 %
(Jun 30 2016)  


MYL's III. Quarter Q/Q Income from Cont. Operations Comment
Mylan N v achieved in the III. Quarter 2020 above company average sequential Income from Cont. Operations doubling of 371.32%, to $ 185.70 millions, from $39.40 millions in the second quarter.
MYL is undergoing a remarkable growth, with reporting above regular growth, and additionally accelerating rate.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Mylan N V 's Income from Cont. Operations growth quarter on quarter, overall rank is 138.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #12
Overall #138
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #12
Overall #138
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
1111.51 % 79.38 % -92.86 %
(Jun 30 2016)  


MYL's III. Quarter Q/Q Income from Cont. Operations Comment
Mylan N v achieved in the III. Quarter 2020 above company average sequential Income from Cont. Operations doubling of 371.32%, to $ 185.70 millions, from $39.40 millions in the second quarter.
Major Pharmaceutical Preparations company is going from strength to strength, not only reporting higher then average increase, but also increasing pace, Sophie  Hall, market expert mentioned.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Mylan N V 's Income from Cont. Operations growth quarter on quarter, overall rank is 138.


Mylan N V 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ 266.40 $ 270.50 $ 62.60 $ 16.80 $ 47.50
Y / Y Income from Cont. Operations Growth (TTM) 460.84 % 686.34 % -73.96 % -95.23 % -95.06 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 50 # 22 # 1769 # 1470 # 0
Seqeuential Income from Cont. Operations Change (TTM) -1.52 % 332.11 % 272.62 % -64.63 % 38.08 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1276 # 25 # 43 # 2500 # 0




Cumulative Income from Cont. Operations growth Comment
Assuming the Mylan N V 's fiscal year would have ended in Sep 30 2020, Mylan N V would have reprted above average annual Income from Cont. Operations surge of 460.84% year on year, of $ 266 millions.
This marks a slow-down of the companys growth trends and from the 686.34% surge in Jun 30 2020.

Among companies within the Healthcare sector 7 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 22 to 50.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
332.11 %
14.72 %
-85.69 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 8
Overall # 50

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
686.34 %
36.63 %
-96.06 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 109
S&P 500 # 1276
Cumulative Income from Cont. Operations growth Comment
Assuming the Mylan N V 's fiscal year would have ended in Sep 30 2020, Mylan N V would have reprted above average annual Income from Cont. Operations surge of 460.84% year on year, of $ 266 millions.
This marks a slow-down of the companys growth trends and from the 686.34% surge in Jun 30 2020.

Among companies within the Healthcare sector 7 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 22 to 50.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
332.11 %
14.72 %
-85.69 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 8
Overall # 50

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
686.34 %
36.63 %
-96.06 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 109
S&P 500 # 1276




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
MYL's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for MYL's Competitors
Income from Cont. Operations Growth for Mylan N V 's Suppliers
Income from Cont. Operations Growth for MYL's Customers

You may also want to know
MYL's Annual Growth Rates MYL's Profitability Ratios MYL's Asset Turnover Ratio MYL's Dividend Growth
MYL's Roe MYL's Valuation Ratios MYL's Financial Strength Ratios MYL's Dividend Payout Ratio
MYL's Roa MYL's Inventory Turnover Ratio MYL's Growth Rates MYL's Dividend Comparisons



Companies with similar Income from Cont. Operations surge for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2020
Tenax Therapeutics Inc -0.15%$ -0.147 millions
Tactile Systems Technology Inc -0.29%$ -0.288 millions
Conmed Corporation-1.72%$ -1.722 millions
Mylan N v -2.16%$ -2.160 millions
Eli Lilly And Company-3.63%$ -3.629 millions
Baxter International Inc -4.27%$ -4.267 millions
Viemed Healthcare Inc -5.27%$ -5.270 millions
Icu Medical Inc-5.94%$ -5.937 millions
Emergent Biosolutions Inc -8.56%$ -8.565 millions
Bruker Corporation-10.08%$ -10.081 millions
Innoviva inc -11.54%$ -11.541 millions
Acadia Healthcare Company Inc -12.08%$ -12.082 millions
Biospecifics Technologies Corp-14.13%$ -14.129 millions
China Health Industries Holdings Inc -15.45%$ -15.449 millions
Encompass Health Corporation-16.23%$ -16.234 millions
Corcept Therapeutics Inc-17.90%$ -17.901 millions
Biotelemetry Inc -18.94%$ -18.942 millions
Intuitive Surgical Inc -20.54%$ -20.542 millions
Utah Medical Products Inc-20.84%$ -20.837 millions
89bio Inc -22.01%$ -22.013 millions
Becton Dickinson And Company-22.09%$ -22.086 millions
Illumina Inc -23.50%$ -23.504 millions
Atrion Corporation-24.51%$ -24.513 millions
Fonar Corp-27.85%$ -27.852 millions
Cyanotech Corp-32.02%$ -32.018 millions
National Healthcare Corp-33.59%$ -33.588 millions
Msa Safety Inc-33.74%$ -33.740 millions
Zynex Inc-34.43%$ -34.432 millions
Dentsply Sirona Inc -36.24%$ -36.235 millions
Semler Scientific Inc -37.45%$ -37.447 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OSPN's Profile

Stock Price

OSPN's Financials

Business Description

Fundamentals

Charts & Quotes

OSPN's News

Suppliers

OSPN's Competitors

Customers & Markets

Economic Indicators

OSPN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071